Reduced risk of liver-related events among patients receiving individualized nutrition-focused remote care in the United States.

Shaminie J Athinarayanan¹, Adam J Wolfberg¹, Priya V Shanmugam¹, Bilal A Hameed², Maurizio Bonacini³

¹Departments of Research,, Virta Health, Denver, Colorado, USA.

²Transplant Hepatology, School of Medicine, University of California, San Francisco, California, USA.

³Mission Gastroenterology and Hepatology, University of California, San Francisco, California, USA.

PubMed DOI

Abstract

BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), can lead to significant morbidity and mortality in adults with type 2 diabetes (T2D) and obesity. This study evaluated whether participation in an individualized, nutrition-focused telemedicine care model emphasizing carbohydrate r…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.